Brexit relocation of EU medicines regulator 'will hit UK researchers hard'

Amsterdam says in its bid to house the EMA that two of Britain's top research agencies would lose much of their business

Two of the UK's foremost research organisations will lose much of their business to Amsterdam if the city is successful in securing the relocation of the EU's medicines regulator, the Netherlands' formal bid for the prized agency claims.

Amsterdam, which has been tipped as an early favourite to secure the European Medicines Agency (EMA), says in its application submitted to the European commission that losing the agency will prove a double blow to London when Brexit forces its move.